Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Boyd, Ashleigh S ^a,b   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INSULIN; INTERLEUKIN 6; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; IMMUNE RESPONSE; INNATE IMMUNITY; INSULIN SYNTHESIS; MACROPHAGE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; POLYMERASE CHAIN REACTION;

ANIMALS; CHEMOKINES; CYTOKINES; EMBRYONIC STEM CELLS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNITY, INNATE; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION;

EID: 77956223977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010965     Document Type: Article

References (33)

1. Boyd AS, Wu DC, Higashi Y, Wood KJ (2008) A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells. Stem Cells 26: 1128-1137.
2. Wu DC, Boyd AS, Wood KJ (2008) Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells 26: 1939-1950.
3. Boyd AS, Higashi Y, Wood KJ (2005) Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev 57: 1944-1969.
4. Carvalho-Gaspar M, Billing JS, Spriewald BM, Wood KJ (2005) Chemokine gene expression during allograft rejection: Comparison of two quantitative PCR techniques. Journal of Immunological Methods 301: 41-52.
5. Turvey SE, Gonzalez-Nicolini V, Kingsley CI, Larregina AT, Morris PJ, et al. (2000) Fas ligand-transfected myoblasts and islet cell transplantation. Transplantation 69: 1972-1976.
6. Yasunami Y, Kojo S, Kitamura H, Toyofuku A, Satoh M, et al. (2005) Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 202: 913-918.
7. Johansson U, Olsson A, Gabrielsson S, Nilsson B, Korsgren O (2003) Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem Biophys Res Commun 308: 474-479.
8. El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL (2005) Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112: 320-331.
9. Kondo T, Morita K, Watarai Y, Auerbach MB, Taub DD, et al. (2000) Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 69: 969-977.
10. Magliocca JF, Held IK, Odorico JS (2006) Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 15: 707-717.
11. Bonde S, Zavazava N (2006) Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24: 2192-2201.
12. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, et al. (2007) Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A 104: 20920-20925.
13. Boyd AS, Wood KJ (2009) Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation 87: 1300-1304.
14. Jones ND, Carvalho-Gaspar M, Luo S, Brook MO, Martin L, et al. (2006) Effector and memory CD8+ T cells can be generated in response to alloantigen independently of CD4+ T cell help. J Immunol 176: 2316-2323.
15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
16. Blyszczuk P, Asbrand C, Rozzo A, Kania G, St-Onge L, et al. (2004) Embryonic stem cells differentiate into insulin-producing cells without selection of nestinexpressing cells. Int J Dev Biol 48: 1095-1104.
17. Rus H, Cudrici C, Niculescu F (2005) The role of the complement system in innate immunity. Immunol Res 33: 103-112.
18. Bertuzzi F, Marzorati S, Maffi P, Piemonti L, Melzi R, et al. (2004) Tissue factor and CCL2/monocyte chemoattractant protein-1 released by human islets affect islet engraftment in type 1 diabetic recipients. J Clin Endocrinol Metab 89: 5724-5728.
19. Kapoor A, Morita K, Engeman TM, Vapnek EM, Hobart M, et al. (2000) Intragraft expression of chemokine gene occurs early during acute rejection of allogeneic cardiac grafts. Transplant Proc 32: 793-795.
20. Poss K, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proceedings of the National Academy of Sciences 94: 10919-10924.
21. Burns WR, Wang Y, Tang PC, Ranjbaran H, Iakimov A, et al. (2005) Recruitment of CXCR3+ and CCR5+ T cells and production of interferongamma-inducible chemokines in rejecting human arteries. Am J Transplant 5: 1226-1236.
22. Adams DH, Hubscher S, Fear J, Johnston J, Shaw S, et al. (1996) Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. Transplantation 61: 817-825.
23. Medzhitov R, Janeway CA, Jr. (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9: 4-9.
24. Olszewski WL (2005) Innate immunity processes in organ allografting-their contribution to acute and chronic rejection. Ann Transplant 10: 5-9.
25. Game DS, Lechler RI (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10: 101-108.
26. Kuttler B, Hartmann A, Wanka H (2002) Long-term culture of islets abrogates cytokine-induced or lymphocyte-induced increase of antigen expression on beta cells. Transplantation 74: 440-445.
27. Nicolls MR, Coulombe M, Gill RG (2001) The basis of immunogenicity of endocrine allografts. Crit Rev Immunol 21: 87-101.
28. Socha-Urbanek K, Urbanek K, Fiedor P (1998) The role of adhesion molecules in allotransplanted islet cells rejection. Prolongation of islet cells allograft survival by antiadhesion treatment. Ann Transplant 3: 5-9.
29. Quigg RJ (2003) Complement and the Kidney. J Immunol 171: 3319-3324.
30. Sacks SH, Zhou W, Andrews PA, Hartley B (1993) Endogenous complement C3 synthesis in immune complex nephritis. Lancet 342: 1273-1274.
31. Koch CA, Khalpey ZI, Platt JL (2004) Accomodation: Preventing injury in transplantation and disease. Journal of Immmunology 172: 5143-5148.
32. El-Sawy T, Miura M, Fairchild R (2004) Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis. Am J Pathol 165: 147-157.
33. Marsh JE, Pratt JR, Sacks SH (1999) Targeting the complement system. Curr Opin Nephrol Hypertens 8: 557-562.